Profile data is unavailable for this security.
About the company
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
- Revenue in SEK (TTM)11.10m
- Net income in SEK-182.48m
- Incorporated2007
- Employees83.00
- LocationQ linea ABDag Hammarskjolds Vag 52 AUPPSALA 752 37SwedenSWE
- Phone+46 184443610
- Websitehttps://www.qlinea.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ContextVision AB | 112.75m | 3.58m | 245.68m | 44.00 | 69.32 | 2.71 | 21.53 | 2.18 | 0.0488 | 0.0488 | 1.57 | 1.25 | 0.9575 | 1.74 | 4.15 | 3,000,769.00 | 3.04 | 30.51 | 3.71 | 45.07 | 97.62 | 98.49 | 3.17 | 28.49 | 4.70 | -- | 0.0847 | -- | -1.15 | 6.51 | -24.60 | 27.25 | -30.69 | -- |
| Clinical Laserthermia Systems AB | 21.27m | -38.38m | 252.43m | 16.00 | -- | 3.49 | -- | 11.87 | -5.02 | -5.02 | 1.08 | 2.32 | 0.3208 | 4.58 | 4.84 | 1,329,313.00 | -57.98 | -116.28 | -63.60 | -248.44 | -63.75 | -556.78 | -180.75 | -872.82 | 2.55 | -5.79 | 0.0039 | -- | 127.04 | 67.47 | 40.32 | -- | -- | -- |
| INIFY Laboratories AB | 20.15m | -61.45m | 275.37m | 34.00 | -- | 2.10 | -- | 13.67 | -1.14 | -1.14 | 0.3705 | 1.72 | 0.1928 | 2.96 | 3.12 | 858,106.10 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
| Karolinska Development AB | 1.74m | -135.74m | 311.10m | 8.00 | -- | 0.1007 | -- | 179.00 | -0.4096 | -0.4096 | 0.0052 | 3.28 | 0.0015 | -- | 0.6263 | 217,250.00 | -11.69 | -2.23 | -11.78 | -2.37 | -- | -- | -7,810.36 | -1,161.99 | -- | -1.49 | 0.0017 | -- | -8.74 | -11.49 | -250.41 | -- | -- | -- |
| Acarix AB | 6.92m | -52.44m | 337.00m | 8.00 | -- | 8.76 | -- | 48.71 | -0.0472 | -0.0472 | 0.0062 | 0.0343 | 0.1196 | 0.1667 | 2.77 | 864,750.00 | -90.68 | -74.33 | -102.27 | -86.47 | 86.15 | 82.37 | -757.98 | -1,298.77 | 7.93 | -805.72 | 0.00 | -- | -0.6249 | 27.28 | 14.97 | -- | -- | -- |
| Mentice AB | 274.49m | -43.31m | 364.23m | 121.00 | -- | 2.89 | -- | 1.33 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
| Ortoma AB | 77.19m | -7.52m | 456.91m | 10.00 | -- | 2.90 | 87.50 | 5.92 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Q linea AB | 11.10m | -182.48m | 457.15m | 83.00 | -- | 1.35 | -- | 41.19 | -35.87 | -35.87 | 1.31 | 17.84 | 0.0429 | 0.4006 | 2.90 | -- | -70.50 | -76.00 | -101.81 | -93.84 | -15.26 | -145.47 | -1,644.30 | -2,820.51 | 10.04 | -30.48 | 0.017 | -- | 369.86 | 114.75 | 15.86 | -- | -34.47 | -- |
| Bactiguard Holding AB | 228.77m | -7.84m | 487.39m | 153.00 | -- | 1.75 | 12.42 | 2.13 | -0.2238 | -0.2238 | 6.53 | 8.99 | 0.381 | 3.44 | 6.91 | 1,495,216.00 | -1.31 | -8.02 | -1.86 | -10.13 | 63.78 | 48.56 | -3.43 | -25.10 | 1.38 | -0.3387 | 0.3410 | -- | -12.64 | 4.22 | 73.69 | -- | -17.92 | -- |
| Modulight Oyj | 71.63m | -48.84m | 514.48m | 71.00 | -- | 1.07 | -- | 7.18 | -0.1172 | -0.1172 | 0.1727 | 1.07 | 0.1254 | -0.7943 | 4.78 | 102,484.90 | -8.55 | -9.90 | -9.25 | -10.66 | 129.94 | 119.43 | -68.15 | -88.50 | 3.46 | -- | 0.081 | -- | 1.74 | -10.65 | 45.65 | -- | 24.38 | -- |
| Gentian Diagnostics ASA | 162.05m | 40.18m | 550.50m | 63.00 | 13.90 | 2.90 | 11.31 | 3.40 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Nanexa AB | 10.58m | -39.06m | 607.32m | 15.00 | -- | 7.57 | -- | 57.42 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
| OssDsign AB | 180.16m | -50.99m | 674.82m | 32.00 | -- | 2.18 | -- | 3.75 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| Optomed Oyj | 181.03m | -70.32m | 677.01m | 111.00 | -- | 2.66 | -- | 3.74 | -0.3374 | -0.3374 | 0.8688 | 1.12 | 0.5363 | 2.87 | 5.07 | 154,009.00 | -20.83 | -17.19 | -25.75 | -20.69 | 63.60 | 64.81 | -38.85 | -34.21 | 2.03 | -8.91 | 0.1014 | -- | 13.67 | 5.61 | -21.83 | -- | 5.30 | -- |
| BioPorto A/S | 51.83m | -123.04m | 682.22m | 48.00 | -- | 12.56 | -- | 13.16 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
Data as of Feb 13 2026. Currency figures normalised to Q linea AB's reporting currency: Swedish Krona SEK
1.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 21 Feb 2025 | 200.05k | 1.06% |
| Handelsbanken Fonder ABas of 31 Dec 2025 | 114.38k | 0.60% |
| Investment AB �resund (Investment Management)as of 31 Dec 2024 | 55.61k | 0.29% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 3.78k | 0.02% |
| SEB Funds ABas of 29 Jan 2025 | 766.00 | 0.00% |
| Danske Bank A/S (Investment Management)as of 31 Jan 2026 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
